S
MRKR icon

SignatureFD’s Marker Therapeutics MRKR Stock Holding History

SignatureFD’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$335 Hold
228
– – ﹤0.01% 3391
2026
Q1 		$296 Buy
+228
New +$362 ﹤0.01% 3354

Other funds holding MRKR

IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
HNB
Hilltop National Bank Casper, Wyoming $468M AUM 36.09% 1-Year Est. Return

SignatureFD's MRKR Position: Q2 2026 in Review

SignatureFD held its Marker Therapeutics (MRKR) position steady in Q2 2026 at 228 shares worth $335. The position accounts for ﹤0.01% of the portfolio, ranked #3391.

SignatureFD first reported a position in MRKR in Q1 2026 and has held it in 2 quarters since. 4 funds tracked by Wall St. Rank hold MRKR as of Q2 2026.

  • SignatureFD held 228 shares of Marker Therapeutics worth $335 as of Q2 2026.
  • SignatureFD left its Marker Therapeutics share count unchanged in Q2 2026.
  • Marker Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3391 holding.
  • SignatureFD first reported a position in Marker Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 4 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.